These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6381337)

  • 21. Maternal herpes simplex virus type 2 coinfection increases the risk of perinatal HIV transmission: possibility to further decrease transmission?
    Bollen LJ; Whitehead SJ; Mock PA; Leelawiwat W; Asavapiriyanont S; Chalermchockchareonkit A; Vanprapar N; Chotpitayasunondh T; McNicholl JM; Tappero JW; Shaffer N; Chuachoowong R
    AIDS; 2008 Jun; 22(10):1169-76. PubMed ID: 18525263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human fibroblast interferon in treatment of viral diseases of the skin and mucous membranes.
    Isacsohn M; Berson B; Sternberg I; Morag A
    Isr J Med Sci; 1983 Nov; 19(11):959-62. PubMed ID: 6319325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment trials of the therapeutic efficacy of the drug "Zovirax" in some recurrent ocular and genital herpetic infections.
    Muţiu A; Sahnazarov N; Crişan I
    Rom J Virol; 1998; 49(1-4):27-42. PubMed ID: 10892424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term suppressive therapy with acyclovir for recurrent genital herpes.
    Baker DA
    J Int Med Res; 1994; 22 Suppl 1():24A-31A; discussion 31A-32A. PubMed ID: 8063021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of recurrent genital herpes with topical alpha interferon gel combined with nonoxynol 9.
    Friedman-Kien AE; Klein RJ; Glaser RD; Czelusniak SM
    J Am Acad Dermatol; 1986 Nov; 15(5 Pt 1):989-94. PubMed ID: 3023457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Placebo-controlled trial of topical interferon in labial and genital herpes.
    Glezerman M; Lunenfeld E; Cohen V; Sarov I; Movshovitz M; Doerner T; Shoham J; Revel M
    Lancet; 1988 Jan; 1(8578):150-2. PubMed ID: 2892991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns, and risk factors.
    Krone MR; Wald A; Tabet SR; Paradise M; Corey L; Celum CL
    Clin Infect Dis; 2000 Feb; 30(2):261-7. PubMed ID: 10671325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV.
    Warren T; Harris J; Brennan CA
    Clin Infect Dis; 2004 Nov; 39 Suppl 5():S258-66. PubMed ID: 15494897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
    Gupta R; Wald A; Krantz E; Selke S; Warren T; Vargas-Cortes M; Miller G; Corey L
    J Infect Dis; 2004 Oct; 190(8):1374-81. PubMed ID: 15378428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An update on short-course episodic and prevention therapies for herpes genitalis.
    Corey L; Bodsworth N; Mindel A; Patel R; Schacker T; Stanberry L
    Herpes; 2007 Jun; 14 Suppl 1():5A-11A. PubMed ID: 17877886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical effect of human-fibroblast-derived (Beta) interferon in treatment of adeno-virus epidemic keratoconjunctivitis and its complications.
    Romano A; Ladizensky E; Guarari-Rotman D; Revel M
    Tex Rep Biol Med; 1981-1982; 41():559-65. PubMed ID: 6302937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin A supplementation and genital shedding of herpes simplex virus among HIV-1-infected women: a randomized clinical trial.
    Baeten JM; McClelland RS; Corey L; Overbaugh J; Lavreys L; Richardson BA; Wald A; Mandaliya K; Bwayo JJ; Kreiss JK
    J Infect Dis; 2004 Apr; 189(8):1466-71. PubMed ID: 15073684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acyclovir suppression to prevent recurrent genital herpes at delivery.
    Scott LL; Hollier LM; McIntire D; Sanchez PJ; Jackson GL; Wendel GD
    Infect Dis Obstet Gynecol; 2002; 10(2):71-7. PubMed ID: 12530483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized, double-blind, placebo-controlled, patient-initiated study of topical high- and low-dose interferon-alpha with nonoxynol-9 in the treatment of recurrent genital herpes.
    Sacks SL; Varner TL; Davies KS; Rekart ML; Stiver HG; DeLong ER; Sellers PW
    J Infect Dis; 1990 Apr; 161(4):692-8. PubMed ID: 2156945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic use of human leukocyte interferon in dermatologic disorders caused by herpes simplex virus. Multicenter study].
    Crespi H; de Mora E; Pueyo S; Jaimovich L; Stringa S; Raimondo E; Grinstein S; Criscuolo M; Davidovich C; Díaz A
    Med Cutan Ibero Lat Am; 1988; 16(6):459-65. PubMed ID: 3073270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of recurrent genital herpes simplex virus infection with recombinant alpha 2 interferon.
    Kuhls TL; Sacher J; Pineda E; Santomauro D; Wiesmeier E; Growdon WA; Bryson YJ
    J Infect Dis; 1986 Sep; 154(3):437-42. PubMed ID: 3525695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukocyte interferon for treating first episodes of genital herpes in women.
    Pazin GJ; Harger JH; Armstrong JA; Breinig MK; Caplan RJ; Cantell K; Ho M
    J Infect Dis; 1987 Dec; 156(6):891-8. PubMed ID: 2824623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical application of human fibroblast interferon (IFN) in cutaneous leishmaniasis.
    Trau H; Schewach-Millet M; Shoham J; Doerner T; Shor R; Passwell JH
    Isr J Med Sci; 1987 Nov; 23(11):1125-7. PubMed ID: 3325468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon efficiency in the treatment of herpetic dermatites. II. Comparison between human leukocyte interferon (Ginterferon) and a recombinant interferon (Roferon).
    Ghyka G; Alecu M; Călugăru A; Coman G
    Med Interne; 1989; 27(3):229-36. PubMed ID: 2515583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of experimental genital herpes with liposomal interferon.
    Kobrinskii GD; Mel'nikov VR; Kulakov VN; L'vov ND; Bolotin IM; Barinskii IF
    Biomed Sci; 1991; 2(1):29-32. PubMed ID: 1912245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.